Teva Pharmaceutical Industries Ltd Earnings

Teva Pharmaceutical Industries Ltd’s revenue jumped 1.54% since last year same period to $3891Mn in the Q1 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -7.99% fall in its revenue since last 3-months.

Teva Pharmaceutical Industries Ltd’s net profit jumped 253.96% since last year same period to $214Mn in the Q1 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 198.62% jump in its net profits since last 3-months.

Teva Pharmaceutical Industries Ltd’s net profit margin jumped 251.62% since last year same period to 5.5% in the Q1 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 207.18% jump in its net profit margins since last 3-months.

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.46 - a -34.01% fall from last quarter’s estimates.

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.46.

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) jumped 8.33% since last year same period to 0.52 in the Q1 2025. This indicates that the Teva Pharmaceutical Industries Ltd has generated 8.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Teva Pharmaceutical Industries Ltd’s return on assets (ROA) stands at 0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Teva Pharmaceutical Industries Ltd’s return on equity (ROE) stands at -0.19.